Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 9 » default

Blood and Lymphatic Cancer: Targets and Therapy


Archive: Volume 9, 2019

The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Lai C, Kandahari AM, Ujjani C

Blood and Lymphatic Cancer: Targets and Therapy 2019, 9:63-71

Published Date: 9 December 2019

Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells

Carrà G, Cartellà A, Maffeo B, Morotti A

Blood and Lymphatic Cancer: Targets and Therapy 2019, 9:45-52

Published Date: 6 November 2019

IDH1-mutated relapsed or refractory AML: current challenges and future prospects

Megías-Vericat JE, Ballesta-López O, Barragán E, Montesinos P

Blood and Lymphatic Cancer: Targets and Therapy 2019, 9:19-32

Published Date: 27 June 2019